ReviewCurrent cancer drug targets2010
The crosstalk of RAS with the TGF-β family during carcinoma progression and its implications for targeted cancer therapy.
Michael Grusch et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
35 papers cite it
this paperpooled itcites it